By Kiran Mazumdar-Shaw The Indian pharmaceutical industry has been playing a key role in improving global health through its affordable and high-quality generic medicines. We are the third largest pharmaceuticals supplier in terms of volume, supplying 60,000 generic brands across 60 therapeutic categories worldwide. India now needs to capture value share as well. To move … Continue reading Budget Offers an Opportunity To Strengthen India’s R&D and Innovation Ecosystem
Technology holds huge promise for healthcare in India in 2022
By Kiran Mazumdar-Shaw The COVID-19 pandemic has caused a digital disruption in healthcare. It has accelerated innovation, catalysed technological breakthroughs, and created a fertile environment for the emergence of low-cost innovations anchored in affordability, and accessibility. It has also forced changes in consumer behaviour, persuaded doctors to become tech-savvy, prompted pharma companies to invest in … Continue reading Technology holds huge promise for healthcare in India in 2022
$150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector
By Kiran Mazumdar-Shaw In the face of the biggest health calamity faced by humanity in a century, India’s Bioeconomy grew over 12% to reach $70.2 billion in 2020. The biotech industry braved the challenges of Covid-19 to develop innovative solutions such as diagnostics, therapies and vaccines at speed and scale to save countless lives. India … Continue reading $150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector
Science, Technology and Innovation: How DBT coordinated India’s COVID-19 fight
By Kiran Mazumdar-Shaw The COVID-19 pandemic has proven that science can rescue humanity. And for science to prosper you need to have dedicated national agencies that are relentlessly driving the agenda of science. Since its inception in 1982, The Department of Biotechnology (DBT) has made tremendous efforts in promoting bioscience research, translational education and entrepreneurship. … Continue reading Science, Technology and Innovation: How DBT coordinated India’s COVID-19 fight
Lessons from the second wave of coronavirus pandemic
By Kiran Mazumdar-Shaw The second Covid-19 wave has hit India, and hit it hard. Record jumps in coronavirus infections on a daily basis have pushed health infrastructure to the brink in several states. While patients are scrambling to secure hospital beds, hospitals are running out of oxygen supplies and critical anti-Covid-19 drugs along with medical … Continue reading Lessons from the second wave of coronavirus pandemic
Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM
By Kiran Mazumdar-Shaw Chairperson, Biocon Group and member of The Lancet Citizen’s Commission on Re-imagining India’s Health System Technology can enable India to leapfrog into an advanced healthcare system that fulfils the vision of the national health policy of promoting wellness, universal access and affordable care for all Indians. The National Digital Health Mission (NDHM) … Continue reading Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM
Invest in Innovation
Kiran Mazumdar Shaw on Expectations from the Union Budget 2020 The budget provides a great opportunity to promote research and innovation in India. The country needs to invest in innovation to harness its potential for tackling the economic challenges confronting us today. This year's budget can provide adequate funding for the development of the kind … Continue reading Invest in Innovation